Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Teva axes Phase 3 trial into chronic cluster headache

June 18, 2018 Research and Development, Sales and Marketing Teva, fremanezumab, headache, pharma

With the advent of another week, there’s another trial discontinuation in the industry as Teva announces its decision to terminate …
News

BMS’ Opdivo becomes first immuno-oncology agent available in China

June 18, 2018 Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, China, NSCLC, lung cancer, oncology, opdivo, pharma

Bristol-Myers Squibb’s flagship immunotherapy Opdivo (nivolumab) has broken ground to become the first and only PD-1 inhibitor to be made …
News

£20bn promised to NHS but questions over where money will come from

June 18, 2018 Medical Communications, Sales and Marketing NHS, UK government, biotech, drugs, pharma, pharmaceutical

Theresa May finally attempted to tackle the elephant in the room for the UK government, well, the one other than …
News

Top Ten most popular articles on Pharmafile.com this week

June 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Another busy in week in pharma has seen a number of companies release promising data on their drugs, Roche’s study …
News

Allergan appoints ex-Abbott exec in “Board refreshment” move

June 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Allergan, appointment, pharma

Allergan has announced another move in its “refreshment” of its executive Board of Directors with the appointment of Thomas C …
News

NICE turns down Roche’s Perjeta for post-surgery HER2-positive breast cancer

June 15, 2018 Medical Communications, Sales and Marketing Cancer, NICE, Perjeta, Roche, breast cancer, pharma

Roche’s ongoing dispute with UK health service watchdog NICE over the availability of its monoclonal antibody Perjeta (pertuzumab) on the …
News

Living with childhood dementia

June 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing childhood dementia, dementia, feature, patient experience, pharma

Claire Young explores her family’s journey through the diagnosis of her son George, who lives with Batten disease, a form …
Feature

FDA knocks back Mylan’s Advair generic for second time

June 14, 2018 Sales and Marketing Advair, FDA, GSK, Mylan, pharma

The FDA has rejected Mylan’s generic version of GlaxoSmithKline’s Advair for the second time following its knockback last year, citing …
News

J&J continues to shed assets, with $2.1bn diabetes unit sale

June 13, 2018 Research and Development, Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

Just last week, Johnson & Johnson announced that it had received an offer from Fortive for its medical sterilisation unit, …
News

Investors stump up cash for anti-ageing start-up

June 12, 2018 Research and Development, Sales and Marketing Juvenescence, biotech, drugs, pharma, pharmaceutical

Defeating the ageing process is a pie-in-the-sky idea that has resulted, so far, in a rich vein of parody rather …
News

Brexit negotiations: Is the public’s health a priority?

June 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical

The Brexit decision has created a huge amount of question marks for many industries and each is vying with each …
Feature

Alexion goes back to roots with Complement deal

June 11, 2018 Manufacturing and Production, Sales and Marketing Alexion, biotech, drugs, pharma, pharmaceutical, soliris

Alexion has made a lot of money from investing in the science behind complement inhibitors – C5 inhibitor, Soliris, has …
News

AbbVie/Roche gain FDA approval for blockbuster treatment

June 11, 2018 Sales and Marketing AbbVie, Roche, biotech, drugs, pharma, pharmaceutical

AbbVie and Roche have a chalked up a major success, after the FDA gave its approval for Venclexta, in combination …
News

Takeda shareholders try to buck Shire deal

June 11, 2018 Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

A small group of Takeda shareholders have started making a lot of noise over its $62 billion deal for Shire, …
News

EU gives nod to expanded label for AZ’s Tagrisso

June 11, 2018 Sales and Marketing AstraZeneca, Tagrisso, biotech, drugs, pharma, pharmaceutical

AstraZeneca has scored another success with Tagrisso in Europe, by receiving an expanded marketing authorisation for Tagrisso in the first-line …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026